Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathway
Xue Han(Hangzhou Medical College), Guang Liang(Hangzhou Medical College), Jian Zhu(Jiangnan University), Diyun Xu(Wenzhou Medical University), Wenwei Zhou(Hangzhou Medical College), Huazhong Ying(Hangzhou Medical College), Jiajia Zhang(Bloomberg (United States)), Jiajia Wei(Zunyi Medical University), Ruyi Zheng(Hangzhou Medical College), Gaojun Wu(Wenzhou Medical University), Yu Tu(Hangzhou Medical College), Qiaojuan Shi(Hangzhou Medical College)
Cited by 12
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
|Nature|2021|546
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer
|JAMA Oncology|2020|498
Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells
|Theranostics|2020|299
Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2
|Nature Communications|2017|263